Gaining Ground: Expanding Options for Advanced HCC - Episode 1

Overview of Hepatocellular Carcinoma Risk Factors

, ,

Ghassan Abou-Alfa, MD leads Robert Lewandowski, MD, FSIR, and Amit Singal, MD in a discussion of the main risk factors for hepatocellular carcinoma.

Now Viewing
EP. 1: Overview of Hepatocellular Carcinoma Risk Factors
EP. 2: Review of Curative Treatment Strategies for HCC
EP. 3: Child-Pugh Scoring System and Liver Function Assessment
EP. 4: Therapy for Locally Advanced HCC
EP. 5: The Advent of Systemic Therapy for HCC
EP. 6: Immune Checkpoint Inhibitors in HCC
EP. 7: Combination Therapy with Immune Checkpoint Inhibitors for HCC
EP. 8: IMbrave-150 and HIMALAYA: Clinical Trials of Immune Checkpoint Inhibitor Combinations in HCC
EP. 9: Immune Checkpoint Inhibitors and Their Effects on Liver Function
EP. 10: Real-World Evidence on Use of Immune Checkpoint Inhibitor Combinations and Clinical Trial Endpoints
EP. 11: Novel Strategies: Combining Systemic and Local Therapies
EP. 12: HCC International Clinical Trials